Resveratrol bioavailability and toxicity in humans CH Cottart, V Nivet‐Antoine, C Laguillier‐Morizot, JL Beaudeux Molecular nutrition & food research 54 (1), 7-16, 2010 | 651 | 2010 |
Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives JL Beaudeux, P Giral, E Bruckert, MJ Foglietti, MJ Chapman Clinical Chemistry and Laboratory Medicine (CCLM) 42 (2), 121-131, 2004 | 300 | 2004 |
Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans CH Cottart, V Nivet‐Antoine, JL Beaudeux Molecular nutrition & food research 58 (1), 7-21, 2014 | 280 | 2014 |
Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells N Ouslimani, J Peynet, D Bonnefont-Rousselot, P Thérond, A Legrand, ... Metabolism 54 (6), 829-834, 2005 | 266 | 2005 |
S100-B protein as a screening tool for the early assessment of minor head injury D Zongo, R Ribéreau-Gayon, F Masson, M Laborey, B Contrand, ... Annals of emergency medicine 59 (3), 209-218, 2012 | 211 | 2012 |
Simple spectrophotometric assessment of the trans-/cis-resveratrol ratio in aqueous solutions L Camont, CH Cottart, Y Rhayem, V Nivet-Antoine, R Djelidi, F Collin, ... Analytica chimica acta 634 (1), 121-128, 2009 | 189 | 2009 |
Serum plasma pregnancy-associated protein A: a potential marker of echogenic carotid atherosclerotic plaques in asymptomatic hyperlipidemic subjects at high cardiovascular risk JL Beaudeux, L Burc, F Imbert-Bismut, P Giral, M Bernard, E Bruckert, ... Arteriosclerosis, thrombosis, and vascular biology 23 (1), e7-e10, 2003 | 188 | 2003 |
Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage N Weiss, P Sanchez-Pena, S Roche, JL Beaudeux, C Colonne, P Coriat, ... The Journal of the American Society of Anesthesiologists 104 (4), 658-666, 2006 | 127 | 2006 |
Radicaux libres et stress oxydant: aspects biologiques et pathologiques J Delattre, JL Beaudeux, D Bonnefont-Rousselot Editions Tec & Doc, 2005 | 124 | 2005 |
Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia JL Beaudeux, P Giral, E Bruckert, M Bernard, MJ Foglietti, MJ Chapman Atherosclerosis 169 (1), 139-146, 2003 | 123 | 2003 |
Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy S Jacqueminet, OB Abdesselam, MJ Chapman, N Nicolay, MJ Foglietti, ... Clinica chimica acta 367 (1-2), 103-107, 2006 | 106 | 2006 |
Increased serum concentrations of soluble receptor for advanced glycation endproducts in patients with type 1 diabetes M Challier, S Jacqueminet, O Benabdesselam, A Grimaldi, JL Beaudeux Clinical Chemistry 51 (9), 1749-1750, 2005 | 101 | 2005 |
High density lipoproteins (HDL) and the oxidative hypothesis of atherosclerosis D Bonnefont-Rousselot, P Thérond, JL Beaudeux, J Peynet, A Le-grand, ... Walter de Gruyter 37 (10), 939-948, 1999 | 97 | 1999 |
Metformin reduces endothelial cell expression of both the receptor for advanced glycation end products and lectin-like oxidized receptor 1 N Ouslimani, M Mahrouf, J Peynet, D Bonnefont-Rousselot, C Cosson, ... Metabolism 56 (3), 308-313, 2007 | 96 | 2007 |
Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes F Ganné, M Vasse, JL Beaudeux, J Peynet, A François, Z Mishal, ... Thrombosis and haemostasis 84 (10), 680-688, 2000 | 93 | 2000 |
Metformin reduces angiotensin-mediated intracellular production of reactive oxygen species in endothelial cells through the inhibition of protein kinase C M Mahrouf, N Ouslimani, J Peynet, R Djelidi, M Couturier, P Therond, ... Biochemical pharmacology 72 (2), 176-183, 2006 | 91 | 2006 |
Diabetes mellitus, oxidative stress and advanced glycation endproducts D Bonnefont-Rousselot, JL Beaudeux, P Therond, J Peynet, A Legrand, ... Annales Pharmaceutiques Francaises 62 (3), 147-157, 2004 | 89 | 2004 |
Influence of hemolysis on the measurement of S-100β protein and neuron-specific enolase plasma concentrations during coronary artery bypass grafting JL Beaudeux, P Leger, L Dequen, I Gandjbakhch, P Coriat, MJ Foglietti Clinical chemistry 46 (7), 989-990, 2000 | 89 | 2000 |
Reference values for serum S-100B protein depend on the race of individuals O Ben Abdesselam, J Vally, C Adem, MJ Foglietti, JL Beaudeux Clinical chemistry 49 (5), 836-837, 2003 | 88 | 2003 |
Cytoprotective effect against UV-induced DNA damage and oxidative stress: role of new biological UV filter T Said, M Dutot, C Martin, JL Beaudeux, C Boucher, E Enee, C Baudouin, ... European Journal of Pharmaceutical Sciences 30 (3-4), 203-210, 2007 | 80 | 2007 |